- Research article
- Open Access
Low birth weight contributed to increased serum IL-6 levels in infantile respiratory syncytial virus infection
BMC Pediatrics volume 17, Article number: 205 (2017)
To evaluate the role of serum cytokines in the pathogenesis of respiratory syncytial virus (RSV) infection in infants with low birth weight (LBW).
A prospective observational study was performed, and hospitalized children with lower respiratory tract infection (LRTI) were recruited. Three hundred fifty-eight patients < 1 year met the inclusion criteria: 116 patients had only RSV infection (RSV group); 242 patients had no RSV or other specific pathogen (non-RSV group). Serum interleukin-2 (IL-2), IL-4, IL-6, IL-10, tumor necrosis factor-α (TNF-α), and interferon-γ (IFN-γ) were detected through flow cytometry.
No significant differences in serum IL-2, 4, 6, 10, and IFN-γ levels were observed between the RSV and non-RSV groups. For RSV infected infants with or without wheezing, delivery mode had no obvious effect on the changes of serum cytokine levels. However, the level of IL-6 in the RSV-infected infants with LBW was significantly higher than that in infants with normal birth weight.
Serum IL-6 level was significantly increased in RSV infected infants with LBW. It is likely that the specific serum cytokine pattern will contribute to our understanding of the pathogenesis of RSV infections, especially in RSV-infected infants with LBW.
Lower respiratory tract infection (LRTI) is the leading cause of global child mortality. Respiratory syncytial virus (RSV) is believed to be the most important viral pathogen causing LRTI in young children. Furthermore, the incidence for severe LRTI was highest in infants aged 0–11 months . RSV is not only the leading pathogen of LRTI including pneumonia and bronchiolitis, but is also closely associated with the development of asthma . A number of clinical epidemiology studies have revealed that there is a strong association between RSV bronchiolitis in infancy and the development of wheezing or asthma in later childhood. About 40% of children after severe RSV bronchiolitis subsequently develop asthma [2, 3]. Despite the importance of RSV as a respiratory pathogen, the underlying mechanisms of the development of subsequent wheezing and asthma following primary RSV infection remain unclear.
RSV infection may increase the susceptibility to developing allergic immune responses by breaking immune tolerance to allergens early in life through regulatory T cells . Moreover, RSV-induced neurogenic inflammation appears to potentiate neural pathways that favor bronchoconstriction and mucus production . Interestingly, studies have shown that infection with RSV also results in a significant increase in proinflammatory cytokines such as interleukin (IL)-1, IL-6, IL-8, interferon (IFN)-γ, and tumor necrosis factor (TNF)-α, contributing to development of recurrent wheezing or asthma . Our previous study has shown that low birth weight (LBW) or intrauterine growth retardation significantly increases the risk of childhood asthma. Children with LBW have an approximately 16% higher risk of asthma compared with those with normal birth weight (NBW) . Another study by Rossi et al. further revealed that LBW was not only associated with the increased risk of asthma or wheezing, but also with RSV infection severity .
Although we recognize the significant role of low birth weight in infantile RSV-induced LRTI or wheezing, the mechanism of this phenomenon remains unknown. In view of the potential role of cytokines, we hypothesized that LBW induces a specific cytokine profile in infantile bronchiolitis or wheezing induced by RSV infection, leading to more significant manifestations related to asthma. The present study aims to evaluate the possible role of cytokines in the pathogenesis of RSV infection in infants with LBW.
In this prospective observational study, hospitalized children with lower respiratory tract infections (LRTI) from the Respiratory Department of the Children’s Hospital of Zhejiang University School of Medicine between January 2013 and December 2014 were recruited. LRTI, including bronchiolitis and pneumonia, has been defined as equivalent to clinical pneumonia, which is characterized by acute onset cough or difficulty breathing with fast breathing for age . Inclusion criteria were hospital admission, LRTI, age <1 year and positive respiratory immunofluorescence detection for RSV . Patients with severe illness and non-severe illness were distinguished by the need for intensive care. Wheezing is defined as a continuous high-pitched sound with musical quality emitting from the chest during expiration . Wheezing symptoms were assessed by at least two clinicians from our study team or the treating physicians (during the weekend). Records on admission age, birth weight, gender, diagnosis, viral pathogen detection, bacterial culture results, laboratory test, length of stay and other relevant medical conditions were collected. Those patients with chronic lung diseases, congenital heart disease, cerebral palsy or tumor were excluded.
Identification of respiratory virus in nasopharyngeal aspirates (NPA)
Samples of nasopharyngeal aspirates (NPA) were obtained from the nasopharynx through catheters after instilling 5 ml of sterile physiologic saline solution into mucus traps at the time of hospitalization. Respiratory immunofluorescence detection via NPA for respiratory syncytial virus (RSV), influenza virus A and B, parainfluenza virus, and adenovirus were carried out. Serum at the time of admission was collected for M. pneumoniae antibody measurements: IgM and IgG to M. pneumoniae were tested by means of an enzyme-linked immunosorbent assay (ELISA) according to the manufacturer’s instructions. M. pneumoniae DNA in NPA specimens was detected by fluorescence quantitative real-time PCR. Meanwhile, sputum cultures were also performed.
Peripheral blood samples were collected at the time of admission. The blood sample was transferred to a serum separating tube and centrifuged at 1000 g at room temperature for 20 min after clotting. The serum was carefully harvested and the measurement of the cytokines was performed by flow cytometry immediately, or the serum was temporarily stored at 2–8 °C until analysis. Concentrations of IL-2, IL-4, IL-6, IL-10, TNF-α, and IFN-γ were quantitatively determined with use of the cytometric bead array (CBA) kit (CBA Human Th1/Th2 Cytokine Kit II; BD Biosciences, San Jose, California) as described previously . The minimal and maximum limits of detection for all cytokines were 1 and 5000 pg/mL, respectively.
Statistical analysis was performed using descriptive statistics such as frequency and percentage, mean and standard error of mean (SEM). The continuous variables between two groups were compared by Student’s t-test. A general linear model was used to assess multiple potential confounders. All data were analyzed with PASW Statistics 18 software (SPSS Inc. Chicago, US). A P-value of less than 0.05 was considered to be statistically significant.
In the present study, 358 children with LRTI < 1 year met the inclusion criteria; 116 patients had only RSV infection (RSV group); 242 patients had no RSV or other specific pathogen infections (non-RSV group). No significant differences in birth weight, days of hospitalization, WBC counts, percentage of neutrophils and eosinophils were observed between the two groups of patients (Table 1). There were also no significant differences in birth weight, days of hospitalization, WBC counts, percentage of neutrophils and eosinophils between LBW (birth weight < 3.0 kg) and NBW (birth weight ≥ 3.0 kg) groups (Table 1). The mean age of the RSV group was significantly lower than that of the non-RSV group (Table 1). In RSV patients, the age of the LBW group was also significantly lower than that of the NBW group (Table 1). The values of C reactive protein (CRP) and procalcitonin (PCT) in both groups were within the normal reference ranges.
Serum cytokine responses in relation to LRTI
In these patients with LRTI, serum IL-2 and IFN-γ levels in both the RSV and non-RSV groups were within the normal reference ranges (shown in Table 2). Although serum IL-4 and IL-10 levels were increased, there were no significantly statistical differences between the two groups. Serum IL-6 levels in the RSV group were similar to those in the non-RSV group. Compared with the increased average serum TNF-α level in the non-RSV group, average serum TNF-α level of the RSV group was within the normal reference range. A significantly statistical difference was observed between the groups (P = 0.024).
Serum cytokine levels in RSV patients
Serum cytokine levels of RSV-infected patients in different subgroups are shown in Table 3. Compared with RSV-infected infants with birth weight ≥ 3.0 kg (NBW), the level of IL-6 in RSV-infected infants with birth weight < 3.0 kg (LBW) was significantly increased. The general linear model revealed that body weight at admission, days of hospitalization, gender, delivery mode, and wheezing were not obviously associated with IL-6 levels. Only low birth weight (P = 0.035) was strongly correlated with changes of serum IL-6 levels. Although average serum TNF-α level in RSV-infected infants with LBW was higher than that in infants with NBW, there was no statistical difference between them. No significant differences in other cytokines were observed between birth weight subgroups. Likewise, for RSV infected infants, delivery mode and wheezing mode had no significant effects on the serum cytokine levels (Table 3).
Serum cytokine levels in RSV infants with wheezing
Serum cytokine levels of RSV-infected infants with wheezing in different subgroups are shown in Table 4. For RSV infected infants with wheezing, delivery mode had no obvious effect on the serum cytokine levels. Although average IL-6 level in the RSV-infected infants with wheezing and LBW was higher than that in infants with wheezing and NBW, there was no statistical difference between them. Average serum TNF-α level in the infants with wheezing and LBW was higher than that in infants with NBW, but there was also no statistical difference between them. No significant differences in other cytokines were observed between birth weight subgroups (Table 4).
Respiratory syncytial virus (RSV) is the leading viral cause of acute LRTI worldwide, and the most important viral pathogen in infancy, especially among young infants less than 6 months . A large number of studies have established a link between infantile RSV infection and wheezing or asthma . Moreover, the increased evidence indicates that cytokines are strongly correlated with the pathogenic mechanism of RSV-induced wheezing or asthma attacks [13,14,15,16,17].
IL-6 is an important proinflammatory cytokine, promoting Th2 cell differentiation and simultaneously inhibiting Th1 cell polarization. TNF-α is another important proinflammatory cytokine that is involved in both acute and chronic inflammatory responses. IL-6 and TNF-α mRNA and protein levels in bronchoalveolar lavage fluid in term infants with RSV bronchiolitis were greater than the control group. However, in preterm infants with RSV bronchiolitis, IL-6 and TNF-α proteins significantly decreased . The decrease in IL-6 and TNF-α protein levels in preterm infants may be correlated with the prolonged clinical course seen in those RSV patients . Another study by Oda et al. demonstrated that serum IL-6 levels from patients with RSV infection were high compared with a control group, but there was no statistical significance . Unlike local cytokine expression, our study indicated that systemic IL-6 levels in the RSV group were also high (greater than normal reference value), but there was no statistical significance compared with the non-RSV group. However, average serum TNF-α level from the RSV group was significantly lower than from the non-RSV group. It is likely that the decreased local or systemic TNF-α levels contributed to the prolonged clinical course and wheezing seen in those infants with RSV infection. Similar to other studies [13, 19, 20], no obvious changes in serum IL-2, 4, 10 and IFN-γ levels were observed in the present study.
A large number of studies have confirmed a link between infantile RSV infection and the development of wheezing or asthma in later childhood . Moreover, individuals with LBW were more inclined to develop severe RSV infection, resulting in an increased risk of wheezing or asthma [6, 7]. The potential mechanism might be explained in part by the fact that serum cytokine concentrations in infants with RSV infection were strongly related to birth weight, not to delivery mode. IL-6 high patients had significantly worse lung function and more frequent asthma exacerbations than IL-6 low patients . Circulating IL-6 is elevated in asthmatic patients and in bronchoalveolar lavage fluid of patients in whom asthma is clinically active. IL-6 levels probably reflect an activated state of the lung, and may have a role as a biomarker for asthma . In the present study, increased serum IL-6 levels in infants with LBW might also play an important role in RSV induced wheezing or asthma. Although average serum IL-6 in RSV patients with wheezing was higher than in those without wheezing, there was no significant difference between them. This phenomenon further indicated that only LBW was likely to cause obvious increases in serum IL-6 levels in infants with RSV infection. In general, IL-6 is moderately increased in virus infections, lower than in Mycoplasma pneumoniae and bacterial infections [11, 23]. The present study also confirmed this trend. It has been previously documented that the levels of pro-inflammatory cytokines such as IL-6 were consistently higher in RSV patients at hospital admission, discharge, and 1 month after discharge than control levels. There was a trend towards greater IL-6 production in RSV infection, but not IFN-γ production . These cytokines recruit inflammatory and immunocompetent cells into the sites of airway inflammation. Therefore, it is likely that the increased IL-6 response in RSV patients with wheezing would provide a substratum for the development of subsequent asthma, resulting in more significant changes related to asthma, especially in children with LBW.
Additionally, a previous study by Rusconi et al. showed that the adjusted risk ratio for development of asthma was 1.33 for elective cesarean delivery compared with spontaneous vaginal delivery . However, Werner et al. found no support for the hypothesis that children delivered by caesarean section have an increased risk of asthma during the first 15–18 years of life . Furthermore, delivery by caesarean section was not clearly associated with hospitalizations for asthma and other wheezing disorders up to 12 years of age compared to vaginal delivery . In view of the potential role of delivery mode in the development of asthma or other wheezing diseases, we also evaluated the possible role of delivery mode in cytokine changes during infantile RSV infections. No obvious changes in serum cytokines were observed between the caesarean section and vaginal delivery groups. Therefore, the present study cannot confirm the correlation between delivery mode and cytokine changes in infantile RSV infections.
Nevertheless, our study has some limitations. Besides the six cytokines in this study, other inflammatory cytokines were reported to be related to pathogenesis of RSV infection, such as IL-5, 13, and 17 . We investigated the above six cytokines only because of the availability of the commercial CBA kit consisting of the six cytokines: IL-2, 4, 6, 10, TNF-α, and IFN-γ. Secondly, because commercial respiratory immunofluorescence kit via NPA in our hospital only detected respiratory syncytial virus (RSV), influenza virus A and B, parainfluenza virus, and adenovirus, not including rhinovirus, we did not perform rhinovirus testing in the present study. It is likely that the RSV-rhinovirus co-infection is the most common co-infection, or Non-RSV infected patients might have rhinovirus infection. Thirdly, although all the samples were collected on admission, we are not certain if they were collected at the same stage of infection. Finally, this study mainly focused on a certain period of hospitalization; long term follow-up study was not performed. Therefore, larger prospective studies are necessary to explore the potential role of serum cytokines in RSV patients with LBW.
In conclusion, our study demonstrated that serum IL-6 level was significantly increased in RSV infected infants with LBW, regardless of wheezing status. It is likely that specific serum cytokine patterns may contribute to the development of wheezing or asthma later in life in RSV-infected individuals, especially in RSV-infected infants with LBW.
C reactive protein
Low birth weight
Lower respiratory tract infection
Normal birth weight
Respiratory syncytial virus
Tumor necrosis factor
Nair H, Simões EAF, Rudan I, Gessner BD, Azziz-Baumgartner E, Zhang JSF, Feikin DR, Mackenzie GA, Moiïsi JC, Roca A, et al. Global and regional burden of hospital admissions for severe acute lower respiratory infections in young children in 2010: a systematic analysis. Lancet. 2013;381(9875):1380–90.
Knudson CJ, Varga SM. The relationship between respiratory syncytial virus and asthma. Vet Pathol. 2015;52(1):97–106.
Zeng R, Li C, Li N, Wei L, Cui Y. The role of cytokines and chemokines in severe respiratory syncytial virus infection and subsequent asthma. Cytokine. 2011;53(1):1–7.
Krishnamoorthy N, Khare A, Oriss TB, Raundhal M, Morse C, Yarlagadda M, Wenzel SE, Moore ML, Peebles RS Jr, Ray A, et al. Early infection with respiratory syncytial virus impairs regulatory T cell function and increases susceptibility to allergic asthma. Nat Med. 2012;18(10):1525–30.
Rossi GA, Colin AA. Infantile respiratory syncytial virus and human rhinovirus infections: respective role in inception and persistence of wheezing. Eur Respir J. 2015;45(3):774–89.
XF X, Li YJ, Sheng YJ, Liu JL, Tang LF, Chen ZM. Effect of low birth weight on childhood asthma: a meta-analysis. BMC Pediatr. 2014;14(1):275.
Rossi GA, Medici MC, Arcangeletti MC, Lanari M, Merolla R, Paparatti UD, Silvestri M, Pistorio A, Chezzi C, Osservatorio RSV Study Group. Risk factors for severe RSV-induced lower respiratory tract infection over four consecutive epidemics. Eur J Pediatr. 2007;166(12):1267–72.
Nair H, Nokes DJ, Gessner BD, Dherani M, Madhi SA, Singleton RJ, O’Brien KL, Roca A, Wright PF, Bruce N, et al. Global burden of acute lower respiratory infections due to respiratory syncytial virus in young children: a systematic review and meta-analysis. Lancet. 2010;375(9725):1545–55.
Bont L, Heijnen CJ, Kavelaars A, van Aalderen WM, Brus F, Draaisma JT, Geelen SM, van Vught HJ, Kimpen JL. Peripheral blood cytokine responses and disease severity in respiratory syncytial virus bronchiolitis. Eur Respir J. 1999;14(1):144–9.
Brand PL, Baraldi E, Bisgaard H, Boner AL, Castro-Rodriguez JA, Custovic A, de Blic J, de Jongste JC, Eber E, Everard ML, et al. Definition, assessment and treatment of wheezing disorders in preschool children: an evidence-based approach. Eur Respir J. 2008;32(4):1096–110.
Xu XF, Li XJ, Liu JL, Wu L, Chen ZM. Serum cytokine profile contributes to discriminating M. pneumoniae pneumonia in children. Cytokine. 2016;86:73–8.
Rodríguez-Martínez CE, Rodríguez DA, Nino G. Respiratory syncytial virus, adenoviruses, and mixed acute lower respiratory infections in children in a developing country. J Med Virol. 2015;87(5):774–81.
JW O, Lee HB, Park IK, Kang JO. Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection. Pediatr Allergy Immunol. 2002;13(5):350–6.
Mobbs KJ, Smyth RL, O’Hea U, Ashby D, Ritson P, Hart CA. Cytokines in severe respiratory syncytial virus bronchiolitis. Pediatr Pulmonol. 2002;33(6):449–52.
McNamara PS, Flanagan BF, Selby AM, Hart CA, Smyth RL. Pro- and anti-inflammatory responses in respiratory syncytial virus bronchiolitis. Eur Respir J. 2004;23(1):106–12.
Legg JP, Hussain IR, Warner JA, Johnston SL, Warner JO. Type 1 and type 2 cytokine imbalance in acute respiratory syncytial virus bronchiolitis. Am J Respir Crit Care Med. 2003;168(6):633–9.
Brown PM, Schneeberger DL, Piedimonte G. Biomarkers of respiratory syncytial virus (RSV) infection: specific neurotrophin and cytokine levels provide increased accuracy in predicting disease severity. Paediatr Respir Rev. 2015;16(4):232–40.
Oshansky CM, Zhang W, Moore E, Tripp RA. The host response and molecular pathogenesis associated with respiratory syncytial virus infection. Future Microbiol. 2009;4(3):279–97.
Oda K, Yamamoto Y. Serum interferon-gamma, interleukin-4, and interleukin-6 in infants with adenovirus and respiratory syncytial virus infection. Pediatr Int. 2008;50(1):92–4.
Garcia C, Soriano-Fallas A, Lozano J, Leos N, Gomez AM, Ramilo O, Mejias A. Decreased innate immune cytokine responses correlate with disease severity in children with respiratory syncytial virus and human rhinovirus bronchiolitis. Pediatr Infect Dis J. 2012;31(1):86–9.
Peters MC, McGrath KW, Hawkins GA, Hastie AT, Levy BD, Israel E, Phillips BR, Mauger DT, Comhair SA, Erzurum SC, et al. Plasma interleukin-6 concentrations, metabolic dysfunction, and asthma severity: a cross-sectional analysis of two cohorts. Lancet Respir Med. 2016;4(7):574–84.
Poynter ME, Irvin CG. Interleukin-6 as a biomarker for asthma: hype or is there something else? Eur Respir J. 2016;48(4):979–81.
Menendez R, Sahuquillo-Arce JM, Reyes S, Martinez R, Polverino E, Cilloniz C, Cordoba JG, Montull B, Torres A. Cytokine activation patterns and biomarkers are influenced by microorganisms in community-acquired pneumonia. Chest. 2012;141(6):1537–45.
Rusconi F, Zugna D, Annesi-Maesano I, Baiz N, Barros H, Correia S, Duijts L, Forastiere F, Inskip H, Kelleher CC, et al. Mode of delivery and asthma at school age in 9 European birth cohorts. Am J Epidemiol. 2017;185(6):465–73.
Werner A, Ramlau-Hansen CH, Jeppesen SK, Thulstrup AM, Olsen J. Caesarean delivery and risk of developing asthma in the offspring. Acta Paediatr. 2007;96(4):595–6.
Leung JY, Li AM, Leung GM, Schooling CM. Mode of delivery and childhood hospitalizations for asthma and other wheezing disorders. Clin Exp Allergy. 2015;45(6):1109–17.
We thank Dr. Sun for her help. We also thank Dr. Elizabeth L. Kramer from Cincinnati Children’s Hospital Medical Center for reviewing this manuscript. We also thank the Zhejiang Key Laboratory for Diagnosis and Therapy of Neonatal Diseases and the Key Laboratory of Reproductive Genetics Ministry of Education for their assistance.
This work was supported by grants from the National Natural Science Foundation of China (No. 81270723), Project of Zhejiang Provincial Department of Education (Y201431434), and Zheng Shu Medical Elite Scholarship Fund. The study sponsors had no involvement in the design of the study, collection, analysis, interpretation of data, and the writing of manuscript.
Availability of data and materials
The datasets generated during and/or analyzed during the current study are available from the corresponding author on reasonable request.
Ethics approval and consent to participate
This study was approved by the Ethic Review Board of the Children’s Hospital, Zhejiang University School of Medicine. Written informed consent was obtained from the parents of each child before enrollment at the start of the study.
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Sheng, YJ., Xu, SS., Li, XJ. et al. Low birth weight contributed to increased serum IL-6 levels in infantile respiratory syncytial virus infection. BMC Pediatr 17, 205 (2017). https://doi.org/10.1186/s12887-017-0961-2
- Lower respiratory tract infection
- Low birth weight
- Respiratory syncytial virus